SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- A new securities class-action lawsuit has been filed against healthcare giant Centene Corporation (NYSE: CNC) and its top executives. The lawsuit alleges that Centene provided a misleadingly optimistic view of its business, particularly concerning its health insurance marketplace enrollment. This follows a dramatic stock price collapse that wiped out billions in market value. Hagens Berman urges Centene investors who suffered substantial losses to submit you ...

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/centene-corporation-lawsuit-submi ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Centene securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by September 8, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Centene's management provided misleading information regarding the company's revenue guidance and earnings per share for the 2025 fiscal year, while concealing adverse facts about enrollment and morbidity rates [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [3]

NEW YORK, Aug. 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Centene, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/centene-corporation-class-action-lawsuit. Investors have until September 8, 2025, to ask the ...

NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), of the important September 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Centene securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth prospects during the specified Class Period from December 12, 2024, to June 30, 2025 [1][4]. Company Overview - Centene Corporation is a healthcare enterprise that provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on underinsured and uninsured individuals [3]. Allegations and Misleading Information - The lawsuit claims that Centene's management misled investors by presenting a false impression of reliable information concerning the company's projected revenue and growth, emphasizing strong enrollment rates and low morbidity levels [4]. - Contrary to these claims, the complaint alleges that there were adverse enrollment trends and worsening morbidity rates that were concealed from investors [5]. Financial Impact and Guidance Revision - On July 1, 2025, Centene withdrew its 2025 guidance, revealing disappointing findings from an internal analysis that indicated market growth across 22 states, which account for approximately 72% of its marketplace membership, was significantly below expectations [6]. - Following this announcement, Centene revised its earnings guidance downward to approximately $1.8 billion, translating to an adjusted diluted EPS of $2.75 [6]. - The stock price of Centene dropped by more than 40% after the guidance revision, resulting in substantial financial harm to investors [7].

Core Insights - Centene Corporation's business model heavily relies on contracts and partnerships, particularly in Medicaid, Medicare, and ACA marketplaces, which provide steady and recurring revenues while enhancing scale advantages [1][8] - The company's growth is significantly driven by winning, renewing, and expanding government contracts, especially state Medicaid contracts, which serve as long-term growth engines [1][3] - Strategic partnerships with state agencies, provider networks, technology partners, and pharmacy benefit managers (PBMs) enhance operational efficiency and improve member outcomes, contributing to better profitability [2][3] Financial Performance - Centene's shares have declined by 52.3% year to date, underperforming the industry [7][8] - The company trades at a forward 12-month price-to-earnings ratio of 11.2, which is below the industry average of 14.7 [9] - Recent consensus estimates for Centene's EPS have been revised downward for the third and fourth quarters of 2025, as well as for the full years of 2025 and 2026 [10][11] Market Position - The Medicaid and ACA markets operate on thinner margins compared to commercial insurance, but Centene mitigates this through disciplined contract execution and strategic partnerships [3][8] - The company's ability to secure and sustain government contracts, along with its disciplined approach to partnerships, positions it for consistent top-line expansion and margin improvement over the long term [4]

Core Viewpoint - A securities class-action lawsuit has been filed against Centene Corporation, alleging that the company misrepresented its business outlook, particularly regarding health insurance marketplace enrollment, leading to a significant stock price decline [1][2]. Group 1: Lawsuit Details - The lawsuit, titled Lunstrum v. Centene Corporation, seeks to represent investors who purchased Centene securities between December 12, 2024, and June 30, 2025 [2]. - The complaint claims that Centene projected a strong outlook based on robust enrollment and favorable morbidity rates, which contradicted the company's internal data [2][5]. - The lawsuit was prompted by Centene's withdrawal of its 2025 financial guidance on July 1, 2025, after an independent actuarial review indicated lower-than-expected market growth and inconsistent morbidity levels [3]. Group 2: Financial Impact - Following the revelation of the misleading information, Centene's stock price fell more than 40% in a single day [3]. - On July 25, 2025, Centene reported a second-quarter diluted loss per share of -$0.51, attributing this loss to reduced revenue estimates [4]. Group 3: Investigation and Legal Representation - Hagens Berman, a national plaintiffs' rights law firm, is investigating the claims against Centene to determine if the company misrepresented the health of its marketplace business [5]. - The firm emphasizes the alleged disconnect between Centene's public optimism and its internal data regarding its critical business segment [5].

Group 1 - Centene (NYSE: CNC) has experienced a significant decline, losing over 60% of its market cap in the past twelve months, leading to a low valuation [1] - The article emphasizes the importance of fundamental analysis in making informed investment decisions, highlighting the author's background in IT and experience in managing a family portfolio [1] - The author aims to provide accessible insights for investors of all experience levels, focusing on various sectors and uncovering promising investment opportunities [1] Group 2 - There is a potential for the author to initiate a long position in Centene (CNC) within the next 72 hours, indicating a possible bullish outlook [2] - The article expresses the author's personal opinions and does not involve any compensation from companies mentioned, ensuring an unbiased perspective [2] - Seeking Alpha clarifies that past performance does not guarantee future results and that the views expressed may not reflect the platform's overall stance [3]

Core Insights - The Interim Housing Accessibility Improvement Fund aims to enhance accessibility at interim housing sites for individuals with disabilities experiencing homelessness, providing grants of up to $100,000 to approximately 85 sites [1][3] - The initiative is part of a $5 million investment from L.A. Care and Health Net's Housing and Homelessness Incentive Program (HHIP), focusing on expanding interim housing options in Los Angeles County [1][2] - Over 25% of adults in the U.S. have some form of physical disability, making them more likely to experience homelessness due to barriers in securing suitable housing [2] Group 1: Initiative Details - The fund will support construction improvement projects that enhance physical access and usability for people with disabilities [1][3] - Eligible applicants include licensed free or community clinics, Federally Qualified Health Centers (FQHCs), public agencies, or tax-exempt 501(c)(3) entities providing interim housing services in Los Angeles County [5][7] - Providers must serve Medi-Cal or uninsured clients and use funds for accessibility-related construction projects aligned with ADA standards [7] Group 2: Organizational Collaboration - The initiative is a collaboration between Brilliant Corners, L.A. Care Health Plan, Health Net, and the Los Angeles County Department of Health Services Housing for Health Division, reflecting a commitment to equity and accessibility [3][4] - Health Net emphasizes the importance of creating inclusive spaces for all individuals, while L.A. Care highlights the critical role of interim housing for unhoused community members [4][9] - The initiative aims to address the intersection of health, housing, and accessibility for historically underserved communities [3][4] Group 3: Additional Resources - A new website has been launched to provide eligible applicants with resources for applying for funding, including FAQs and technical assistance [5][6] - An informational webinar is scheduled for September 10, 2025, to provide an overview of the application process and timeline for award determinations [7]